Fig. 3 | British Journal of Cancer

Fig. 3

From: Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study

Fig. 3

Progression-free survival and overall survival according to IL-6 concentration. a, b The baseline plasma concentrations of IL-6 are significantly associated with survival. c, d Alterations in the IL-6 concentration from baseline to after the second cycle are associated with survival. IL-6 interleukin-6, CI confidence interval, NR not reached

Back to article page